FY2027 Earnings Estimate for QIPT Issued By Leede Financial

Quipt Home Medical Corp. (NASDAQ:QIPT) – Investment analysts at Leede Financial issued their FY2027 earnings per share estimates for Quipt Home Medical in a research report issued to clients and investors on Tuesday, February 11th. Leede Financial analyst D. Loe forecasts that the company will post earnings of ($0.10) per share for the year. The consensus estimate for Quipt Home Medical’s current full-year earnings is ($0.05) per share.

Quipt Home Medical Stock Performance

Shares of QIPT stock opened at $2.90 on Thursday. Quipt Home Medical has a 12 month low of $2.30 and a 12 month high of $4.98. The stock has a market capitalization of $124.92 million, a P/E ratio of -19.24 and a beta of 0.57. The company has a current ratio of 1.20, a quick ratio of 0.86 and a debt-to-equity ratio of 0.73. The firm’s 50 day moving average is $2.89 and its 200 day moving average is $2.86.

Quipt Home Medical (NASDAQ:QIPT) last announced its quarterly earnings data on Monday, February 10th. The company reported ($0.03) earnings per share (EPS) for the quarter. Quipt Home Medical had a negative net margin of 2.66% and a negative return on equity of 6.18%.

Hedge Funds Weigh In On Quipt Home Medical

Several hedge funds have recently bought and sold shares of QIPT. SG Americas Securities LLC purchased a new stake in shares of Quipt Home Medical in the third quarter worth $44,000. Atom Investors LP purchased a new stake in shares of Quipt Home Medical in the 3rd quarter valued at about $51,000. XTX Topco Ltd bought a new stake in shares of Quipt Home Medical during the 3rd quarter valued at about $54,000. Wells Fargo & Company MN grew its holdings in shares of Quipt Home Medical by 30.9% during the fourth quarter. Wells Fargo & Company MN now owns 23,851 shares of the company’s stock worth $73,000 after purchasing an additional 5,625 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Quipt Home Medical by 68.7% in the third quarter. JPMorgan Chase & Co. now owns 30,403 shares of the company’s stock worth $89,000 after purchasing an additional 12,383 shares during the last quarter. Hedge funds and other institutional investors own 42.85% of the company’s stock.

Insiders Place Their Bets

In related news, VP Patrick Dennis Gamble bought 17,000 shares of Quipt Home Medical stock in a transaction on Thursday, December 26th. The stock was acquired at an average price of $2.45 per share, with a total value of $41,650.00. Following the acquisition, the vice president now directly owns 40,057 shares of the company’s stock, valued at $98,139.65. This represents a 73.73 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 13.40% of the company’s stock.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.